Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Drugging “undruggable” transcription factor drivers in cancer

Dr John Bushweller - Unviersity of Virgina, Virginia, USA
Drugging “undruggable” transcription factor drivers in cancer ( Dr John Bushweller - Unviersity of Virgina, Virginia, USA )
28 Apr 2016

Pembrolizumab yielded durable responses in patients with advanced Merkel cell carcinoma

Dr Paul Nghiem - University of Washington, Seattle, USA
Pembrolizumab yielded durable responses in patients with advanced Merkel cell carcinoma ( Dr Paul Nghiem - University of Washington, Seattle, USA )
28 Apr 2016

Combination therapy before surgery improves outcomes for patients with HER2 positive breast cancer

Dr Angela DeMichele - Perelmen School of Medicine, University of Pennsylvania, Philadelphia, USA
Combination therapy before surgery improves outcomes for patients with HER2 positive breast cancer ( Dr Angela DeMichele - Perelmen School of Medicine, University of Pennsylvania, Philadelphia, USA )
28 Apr 2016

Elucidation and pharmacological targeting of tumour checkpoint dependencies

Dr Andrea Califano - Colombia University Medical Centre, New York, USA
Elucidation and pharmacological targeting of tumour checkpoint dependencies ( Dr Andrea Califano - Colombia University Medical Centre, New York, USA )
28 Apr 2016

Metastasis intiation mediated by thrombospondin 2

Dr Ilaria Malanchi - Crick Institute, London, UK
Metastasis intiation mediated by thrombospondin 2 ( Dr Ilaria Malanchi - Crick Institute, London, UK )
27 Apr 2016

New technology can potentially overcome CAR T-cell limitations

Dr Philip Low - Purdue University, West Lafayette, USA
New technology can potentially overcome CAR T-cell limitations ( Dr Philip Low - Purdue University, West Lafayette, USA )
27 Apr 2016

AML17 Trial results: maximum dosage of daunorubicin in AML

Dr Mike Dennis - Christie Hospital NHS Foundation Trust, Manchester, UK
AML17 Trial results: maximum dosage of daunorubicin in AML ( Dr Mike Dennis - Christie Hospital NHS Foundation Trust, Manchester, UK )
27 Apr 2016

AML during pregancy

Dr Sahra Ali - Hull and East Yorkshire Hospitals NHS Trust, Hull, UK
AML during pregancy ( Dr Sahra Ali - Hull and East Yorkshire Hospitals NHS Trust, Hull, UK )
27 Apr 2016

Germ line predisposition to leukaemia

Dr Kevin Shannon - UCSF Helen Diller, San Francisco, USA
Germ line predisposition to leukaemia ( Dr Kevin Shannon - UCSF Helen Diller, San Francisco, USA )
27 Apr 2016

The future of haematopathology

Prof Alberto Zamo - University of Verona, Verona, Italy
The future of haematopathology ( Prof Alberto Zamo - University of Verona, Verona, Italy )
27 Apr 2016

Frontline therapy in young patients with myeloma

Prof Philippe Moreau - University of Nantes, Nantes, France
Frontline therapy in young patients with myeloma ( Prof Philippe Moreau - University of Nantes, Nantes, France )
27 Apr 2016

Genomics of childhood ALL

Prof Shai Izraeli - Sheba Medical Centre, Ramat Gan, Israel
Genomics of childhood ALL ( Prof Shai Izraeli - Sheba Medical Centre, Ramat Gan, Israel )
27 Apr 2016